Coloplast A/S (OTCMKTS:CLPBY) Sets New 1-Year Low – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares hit a new 52-week low on Monday . The company traded as low as $7.71 and last traded at $7.72, with a volume of 21594 shares traded. The stock had previously closed at $7.81.

Analyst Ratings Changes

Separately, Sanford C. Bernstein upgraded shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Coloplast A/S currently has an average rating of “Hold”.

Coloplast A/S Price Performance

The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 1.20. The company has a market capitalization of $17.49 billion, a P/E ratio of 28.74, a P/E/G ratio of 0.75 and a beta of 0.26. The company has a 50 day moving average price of $8.59 and a 200 day moving average price of $9.04.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings results on Friday, February 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a return on equity of 27.08% and a net margin of 14.35%.The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.12 billion. On average, equities analysts predict that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.